Newsletters

BACK TO NEWSLETTERS

Newsletter

News-At-A-Glance

Date: December 13th, 2016

President Obama signed the 21st Century Cures Act into law on December 13, 2016. The Cures Act will hasten how drugs and medical devices are reviewed and authorized by the Food and Drug Administration (FDA). The Alliance recently released a statement on the Cures Act. Read it here.    Last month, the ACT-AD (Accelerate Cures/Treatments for Alzheimer's Disease) Coalition hosted its Ninth Annual FDA/Alzheimer's Disease Allies Meeting to discuss the current state of Alzheimer's disease treatment development. You can find a full recap


A Birthday Party to Celebrate Aging Research

Date: July 16th, 2014

Talaya Waller turned 29 recently. And to celebrate she threw a big party in Washington, D.C., on June 21. While the party was a great success, what was even more meaningful was the main reason she put together the event: She did it in honor of her grandmother and to aid research behind the causes of aging. “For most people, a 29th birthday may not carry much significance as other milestone birthdays," she says. "However, for my 29th birthday, I had the urge to do something


Helping Stop a Devastating Disease: The ACT-AD Coalition Continues its Important Work in Alzheimer's Disease

Date: February 1st, 2013

Alzheimer's disease is a slow, dehumanizing, and fatal disease that strikes 1 in 8 people over the age of 65. While it's typically thought of as a disease that affects memory, it goes well beyond memory loss and eventually leads to death. The disease progresses gradually as abnormal proteins—called plaques and tangles—accumulate in the brain and kill healthy cells. It starts out in the part of the brain where memories are formed, which is often the time when an individual seeks